-
admin
Posts
Pilly Labs Collagen Gummies Under Review: Best Collagen Supplement for Better Skin, Joints and Hair Health on the Market
Clinically-Inspired Pilly Labs Collagen Gummies Combine Hydrolyzed Collagen, Vitamin C, and Biotin to Support Skin Elasticity, Joint Flexibility, and Hair Health. Chicago, April 26, 2025...
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of e.l.f. Beauty
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In e.l.f. Beauty To Contact Him Directly To Discuss Their...
Best Legal Steroids For Muscle Growth: Top Anabolic Steroids Alternatives For (Bulking & Bodybuilding) That Really Work – By Crazy Bulk
After six months of research on the ingredients and thousands of feedback from real consumers, we can safely say that legal steroids are 100% legal...
Three-Year Data of Zenflow’s Spring System Demonstrate Durability of Clinical Benefits for Patients Suffering from BPH
Data Presented at the AUA Meeting Reflect Longest-Term Data among FIT Interventions SOUTH SAN FRANCISCO, Calif., April 26, 2025 (GLOBE NEWSWIRE) — Zenflow, Inc. announced...
CG Oncology Announces Best-in-Disease Durability Data in BOND-003 Cohort C and Promising Early Signal in Cohort P for Cretostimogene Grenadenorepvec at the American Urological Association Annual Meeting
– Robust 24-month complete response rate of 42.3% by K-M for cretostimogene monotherapy in BOND-003 Cohort C – – 58.3% of patients showed durable complete...
IO Biotech Showcases Scientific Leadership Through Cancer Vaccines Educational Session at the American Association for Cancer Research (AACR) Annual Meeting 2025
NEW YORK, April 26, 2025 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulatory, off-the-shelf therapeutic cancer vaccines, today announced...
Johnson & Johnson’s TAR-200 monotherapy achieves high disease-free survival of more than 80 percent in BCG-unresponsive, high-risk papillary NMIBC
First results from SunRISe-1 (Cohort 4) show strong disease-free survival rates across high-grade papillary tumours, demonstrating the potential for bladder preservation with 94 percent of...
ONO PHARMA USA Announces 2025 Golden Ticket CompetitionNow Accepting Applications from Innovative Startups
Ono Partnering with LabCentral and MBC BioLabs for Fifth Consecutive Year CAMBRIDGE, Mass., April 27, 2025 /PRNewswire/ — ONO PHARMA USA today announced partnerships with...
Chery Debuts All-New HIMLA Series at 2025 Shanghai Auto Show, Redefining the Pickup Market with Full-Category Lineup
SHANGHAI, April 26, 2025 /PRNewswire/ — On April 23, under the spotlight at 2025 Shanghai Auto Show, Chery officially unveiled its all-new pickup series—HIMLA—marking a key...
ARBOR Technology to Showcase Latest Automation Solutions at Automate 2025, Powering Machine Vision, AMR, and Smart Retail Applications
DETROIT, April 26, 2025 /PRNewswire/ — ARBOR Technology, a leading provider of industrial-grade embedded computing solutions, is excited to announce its participation in Automate 2025,...
